###begin article-title 0
beta-Lactam Resistance Response Triggered by Inactivation of a Nonessential Penicillin-Binding Protein
###end article-title 0
###begin p 1
Conceived and designed the experiments: AO. Performed the experiments: BM AD CJ LZ. Analyzed the data: BM AD JB SH AO. Contributed reagents/materials/analysis tools: AD JB SH. Wrote the paper: BM JB SH AO.
###end p 1
###begin p 2
###xml 417 439 414 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas aeruginosa</italic>
###xml 818 826 809 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 828 835 819 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 902 906 893 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dacB</italic>
###xml 417 439 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
###xml 526 534 <span type="species:ncbi:9606">patients</span>
It has long been recognized that the modification of penicillin-binding proteins (PBPs) to reduce their affinity for beta-lactams is an important mechanism (target modification) by which Gram-positive cocci acquire antibiotic resistance. Among Gram-negative rods (GNR), however, this mechanism has been considered unusual, and restricted to clinically irrelevant laboratory mutants for most species. Using as a model Pseudomonas aeruginosa, high up on the list of pathogens causing life-threatening infections in hospitalized patients worldwide, we show that PBPs may also play a major role in beta-lactam resistance in GNR, but through a totally distinct mechanism. Through a detailed genetic investigation, including whole-genome analysis approaches, we demonstrate that high-level (clinical) beta-lactam resistance in vitro, in vivo, and in the clinical setting is driven by the inactivation of the dacB-encoded nonessential PBP4, which behaves as a trap target for beta-lactams. The inactivation of this PBP is shown to determine a highly efficient and complex beta-lactam resistance response, triggering overproduction of the chromosomal beta-lactamase AmpC and the specific activation of the CreBC (BlrAB) two-component regulator, which in turn plays a major role in resistance. These findings are a major step forward in our understanding of beta-lactam resistance biology, and, more importantly, they open up new perspectives on potential antibiotic targets for the treatment of infectious diseases.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 496 518 487 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas aeruginosa</italic>
###xml 603 611 591 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 616 623 604 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 496 518 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Decades after their discovery, beta-lactams remain key components of our antimicrobial armamentarium for the treatment of infectious diseases. Nevertheless, resistance to these antibiotics is increasing alarmingly. There are two major bacterial strategies to develop resistance to beta-lactam antibiotics: the production of enzymes that inactivate them (beta-lactamases), or the modification of their targets in the cell wall (the essential penicillin-binding proteins, PBPs). Using the pathogen Pseudomonas aeruginosa as a model microorganism, we show that high-level (clinical) beta-lactam resistance in vitro and in vivo frequently occurs through a previously unrecognized, totally distinct resistance pathway, driven by the mutational inactivation of a nonessential PBP (PBP4) that behaves as a trap target for beta-lactams. We show that mutation of this PBP determines a highly efficient and complex beta-lactam resistance response, triggering overproduction of the chromosomal beta-lactamase AmpC and the specific activation of a two-component regulator, which in turn plays a key role in resistance. These findings are a major step forward in our understanding of beta-lactam resistance biology, and, more importantly, they open up new perspectives on potential antibiotic targets for the treatment of infectious diseases.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 455 458 449 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Poole1">[1]</xref>
Decades after their discovery, beta-lactams remain key components of our antimicrobial armamentarium for the treatment of infectious diseases. Bacterial resistance to them is generally driven either by the production of enzymes that inactivate them (beta-lactamases), or by the modification of their targets in the cell wall (penicillin-binding Proteins, PBPs), sometimes in conjunction with mechanisms leading to diminished permeability or active efflux [1].
###end p 6
###begin p 7
###xml 179 203 176 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 245 266 242 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 365 368 362 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Zapun1">[2]</xref>
###xml 515 518 509 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Livermore1">[3]</xref>
###xml 634 652 625 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Enterobacteriaceae</italic>
###xml 657 679 648 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas aeruginosa</italic>
###xml 783 786 774 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Vincent1">[4]</xref>
###xml 179 203 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 245 266 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 657 679 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
###xml 763 771 <span type="species:ncbi:9606">patients</span>
While the acquisition of modified PBPs showing low affinity for beta-lactams is well known to be a major resistance mechanism in Gram-positive cocci, such as penicillin-resistant Streptococcus pneumoniae or the much-feared methicillin-resistant Staphylococcus aureus, this mechanism has not been thought to be important for most species of Gram-negative rods (GNR) [2]. The production of intrinsic or horizontally acquired beta-lactamases is undoubtedly the predominant resistance mechanism in the latter organisms [3]. Among GNRs, the most widely distributed beta-lactamases are chromosomally-encoded AmpC variants, produced by most Enterobacteriaceae and Pseudomonas aeruginosa, high up the list of pathogens causing life-threatening infections in hospitalized patients world-wide [4].
###end p 7
###begin p 8
###xml 204 207 198 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Livermore1">[3]</xref>
###xml 458 461 452 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Livermore1">[3]</xref>
###xml 675 678 666 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Livermore2">[5]</xref>
###xml 679 682 670 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Juan1">[6]</xref>
###xml 711 729 702 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Enterobacteriaceae</italic>
###xml 734 747 725 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 747 750 738 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Juan1">[6]</xref>
###xml 751 754 742 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Langaee1">[9]</xref>
###xml 870 874 861 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Lindberg1">[10]</xref>
###xml 875 879 866 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Normark1">[12]</xref>
###xml 960 964 951 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampC</italic>
###xml 975 979 966 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Lindberg2">[13]</xref>
###xml 980 984 971 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Kong1">[15]</xref>
###xml 734 747 <span type="species:ncbi:287">P. aeruginosa</span>
Although AmpC is produced at very low basal levels in wild-type strains, its expression is highly inducible in the presence of certain beta-lactams (beta-lactamase inducers) such as cefoxitin or imipenem [3]. In fact, the efficacy of the widely-used broad spectrum penicillins (such as piperacillin) and cephalosporins (such as ceftazidime) relies on the fact that they are very weak AmpC inducers, even though they are efficiently hydrolyzed by this enzyme [3]. Unfortunately, mutants showing constitutive high level AmpC production (AmpC derepressed mutants) are frequently selected during treatment with these beta-lactams, leading to the failure of antimicrobial therapy [5],[6]. In some natural strains of Enterobacteriaceae and P. aeruginosa[6]-[9], the inactivation of AmpD (cytosolic N-acetyl-anhydromuramyl-L-alanine amidase involved in peptidoglycan recycling [10]-[12]), and point mutations in AmpR (LysR-type transcriptional regulator required for ampC induction [13]-[15]) have been found to lead to AmpC overexpression, and thus to beta-lactam resistance.
###end p 8
###begin p 9
###xml 120 133 117 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 143 151 140 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 153 160 150 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 246 258 243 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli dacB</italic>
###xml 319 323 316 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Kishida1">[16]</xref>
###xml 324 328 321 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Ghosh1">[17]</xref>
###xml 466 470 460 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampC</italic>
###xml 536 540 530 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Avison1">[18]</xref>
###xml 120 133 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 246 253 <span type="species:ncbi:562">E. coli</span>
In this paper we show that, in contrast to the current expectations, the mutations triggering beta-lactam resistance in P. aeruginosa, whether in vitro, in vivo, or in the clinical setting, frequently arise within a PBP gene. Inactivation of the E. coli dacB ortholog, encoding the nonessential low molecular mass PBP4 [16],[17], is demonstrated to be the principal route to one-step high level (clinical) beta-lactam resistance, by triggering the overexpression of ampC and the specific activation of the CreBC two component regulator [18], which is also found to play a major role in resistance.
###end p 9
###begin title 10
Results/Discussion
###end title 10
###begin title 11
###xml 12 25 12 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 96 104 93 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 109 116 106 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 12 25 <span type="species:ncbi:287">P. aeruginosa</span>
Mutation of P. aeruginosa PBP4 is the main driver of one-step high-level beta-lactam resistance in vitro and in vivo
###end title 11
###begin p 12
###xml 93 97 90 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Plasencia1">[19]</xref>
###xml 186 194 183 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 229 236 226 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 462 466 455 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mutS</italic>
###xml 509 513 498 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mutS</italic>
###xml 302 307 <span type="species:ncbi:10090">mouse</span>
The mechanisms by which beta-lactam resistance arises were studied in a previously described [19] collection of 36 independent ceftazidime resistant mutants. These mutants were obtained in vitro (one-step spontaneous mutants) or in vivo (after 3 days of treatment with humanized ceftazidime regimen in mouse model of lung infection), at two ceftazidime concentrations (4 and 16 microg/ml), and from the wild-type strain PAO1 (normal mutation rate supply) or its mutS deficient hypermutable derivative PAODeltamutS (high mutation rate supply). In the previous study, all the mutants were shown to be highly resistant to all tested penicillins, cephalosporins, and monobactams; overexpression of the chromosomal cephalosporinase AmpC (18 to 236-fold higher expression relative to wild-type) was found to be the instrument of beta-lactam resistance in all cases.
###end p 12
###begin p 13
###xml 183 187 183 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampC</italic>
###xml 219 223 219 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 225 229 225 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampE</italic>
###xml 231 237 231 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampDh2</italic>
###xml 239 245 239 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampDh3</italic>
###xml 250 254 250 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampR</italic>
###xml 359 363 359 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 394 399 394 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampDE</italic>
###xml 475 483 475 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000353.s001">Table S1</xref>
###xml 644 651 644 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 665 669 661 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mutS</italic>
###xml 787 791 779 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 910 914 902 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 1052 1060 1044 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000353.s001">Table S1</xref>
###xml 1144 1148 1136 1140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 1153 1157 1145 1149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampE</italic>
###xml 1184 1189 1176 1181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampDE</italic>
###xml 1220 1224 1212 1216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 1241 1245 1233 1237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampE</italic>
In this work, in an attempt to find out the genetic mechanisms leading to AmpC hyperproduction, we sequenced and quantified the expression of all genes so far known to be involved in ampC regulation and overexpression (ampD, ampE, ampDh2, ampDh3 and ampR) in the 36 mutants. We also performed complementation experiments with plasmids harboring the wild-type ampD gene (pUCPAD) or the complete ampDE operon (pUCPADE). A complete report of the obtained results is provided in Table S1. In contrast to present models, almost none of the mutants (32 of 36) showed mutations in any of the loci examined. The only exceptions were 4 mutants obtained in vivo from PAODeltamutS (high mutation rate supply) at the low ceftazidime concentration (4 microg/ml), each showing a different mutation in ampD. A modified expression of any of the studied genes was neither observed in the 32 mutants. As expected, only the four ampD mutants showed positive complementation with pUCPAD, but, intriguingly, all the 36 mutants showed positive complementation with pUCPADE (Table S1). Furthermore, positive complementation required the simultaneous presence of both ampD and ampE, since plasmids harboring ampDE operons with a non functional ampD and a wild-type ampE also failed to complement the resistance phenotype.
###end p 13
###begin p 14
###xml 79 83 79 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 87 91 87 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampR</italic>
###xml 124 132 124 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 136 143 136 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 228 241 225 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 336 349 333 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 634 638 628 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Plasencia1">[19]</xref>
###xml 767 769 757 759 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 826 828 816 818 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 831 833 821 823 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 846 850 832 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mutS</italic>
###xml 228 241 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 336 349 <span type="species:ncbi:287">P. aeruginosa</span>
These findings suggested that, contrary to current understanding, mutations in ampD or ampR are not at all the most common, in vitro or in vivo, leading to AmpC overexpression and high level (clinical) beta-lactam resistance in P. aeruginosa. Furthermore, the results strongly suggest that one-step high-level ceftazidime resistance in P. aeruginosa mainly occurs through single mutations in a gene/genes previously unknown to be involved in beta-lactam resistance or AmpC regulation. That a single mutation has to be responsible for the resistance phenotype is shown by the ceftazidime resistance mutation rates published previously [19]. At two different ceftazidime concentrations (4 and 16 microg/ml), spontaneous resistant mutants were obtained with a rate of 10-8 mutations per cell division for wild-type PAO1 and of 10-5-10-6 for PAODeltamutS. These mutation rates should rule out the involvement of more than one mutation in the resistance phenotype.
###end p 14
###begin p 15
###xml 192 200 189 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 350 363 347 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 363 367 360 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Dtsch1">[20]</xref>
###xml 425 433 422 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000353-g001">Figure 1</xref>
###xml 580 592 577 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli dacB</italic>
###xml 653 657 650 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Kishida1">[16]</xref>
###xml 658 662 655 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Ghosh1">[17]</xref>
###xml 821 829 818 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000353-g001">Figure 1</xref>
###xml 831 839 828 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000353.s001">Table S1</xref>
###xml 996 1004 993 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000353-g001">Figure 1</xref>
###xml 1213 1221 1210 1218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000353.s001">Table S1</xref>
###xml 350 363 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 580 587 <span type="species:ncbi:562">E. coli</span>
In an attempt to detect the mutations in the gene(s) yet unknown to be involved in beta-lactam resistance, we followed a whole-genome analysis approach. Four of the PAO1 ceftazidime resistant in vitro mutants were analyzed by comparative hybridization on a recently described microarray for the discovery of single nucleotide polymorphisms (SNPs) in P. aeruginosa[20] using the parental PAO1 strain as reference. As shown in Figure 1, major decreases in hybridization ratios (indicating deletions of 50-100 base pairs) were detected for two of the mutants in the gene PA3047, the E. coli dacB ortholog, encoding the nonessential low molecular mass PBP4 [16],[17]. PCR and sequencing confirmed the presence of the deletions in this gene [(nts 1149-1231 for one of the mutants (1A5) and nts 1069-1138 for the other (1D7)] (Figure 1, Table S1). Furthermore, the two remaining mutants (1A1 and 1D4) also revealed a less pronounced decrease of hybridization ratio at a single position in gene PA3047 (Figure 1); PCR and sequencing identified as well the mutations, a G to A change in nt 819 leading to a premature stop codon (W273X) for 1A1 and a A to C change in nt 235 leading to a missense mutation (T79P) for 1D4 (Table S1).
###end p 15
###begin title 16
Comparative genome hybridization of four spontaneous ceftazidime-resistant mutants revealing mutations in gene PA3047.
###end title 16
###begin p 17
###xml 182 183 182 183 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Genomic DNA from mutants 1A1, 1A5, 1D4, and 1A7 was analyzed on a whole genome DNA tiling microarray and compared to the parental wildtype PAO1. Data points (stems) represent the log2 ratio of signal intensity of each mutant against the wildtype signal. Mutants 1A5 and 1A7 showed strong decreases in signal at three consecutive positions (*), indicating deletions. In mutant 1A1 and 1D4, a slight decrease in signal (+) pointed towards a small genetic change, e.g., a single point mutation.
###end p 17
###begin p 18
###xml 75 82 75 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 346 350 346 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Ghosh1">[17]</xref>
###xml 351 355 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Korat1">[21]</xref>
###xml 356 360 356 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Meberg1">[22]</xref>
###xml 387 394 387 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 429 433 429 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Kishida1">[16]</xref>
###xml 636 649 633 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 684 691 681 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 745 752 742 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 757 770 754 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 801 810 798 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000353.s004">Figure S1</xref>
###xml 75 82 <span type="species:ncbi:562">E. coli</span>
###xml 387 394 <span type="species:ncbi:562">E. coli</span>
###xml 636 649 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 684 691 <span type="species:ncbi:562">E. coli</span>
###xml 745 752 <span type="species:ncbi:562">E. coli</span>
###xml 757 770 <span type="species:ncbi:287">P. aeruginosa</span>
The function and structure of PBP4 (DacB) has been characterized mainly in E. coli. The protein is a nonessential low molecular mass class C PBP with DD-carboxypeptidase and DD-endopeptidase activity, that is thought to play an auxiliary role in morphology maintenance, peptidoglycan maturation and recycling, and cell separation during division [17],[21],[22]. The crystal structure of E. coli PBP4 has been recently determined [16] and found to be organized in three domains. Domain I has the characteristic SXXK, SXN, and KTG motifs of PBPs and beta-lactamases, and contains the other two extra domains embedded within it. PBP4 from P. aeruginosa shows a 27% identity with that of E. coli, and contains all conserved motifs. The alignment of E. coli and P. aeruginosa PBP4 sequences is included in Figure S1.
###end p 18
###begin p 19
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dacB</italic>
###xml 220 228 220 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000353.s001">Table S1</xref>
###xml 282 286 282 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 304 308 304 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dacB</italic>
###xml 588 601 588 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 603 612 603 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000353.s004">Figure S1</xref>
###xml 614 622 614 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000353.s001">Table S1</xref>
###xml 588 601 <span type="species:ncbi:287">P. aeruginosa</span>
Following the discovery of mutations within the dacB ortholog, we sequenced this gene in the rest of the collection of the 36 ceftazidime resistant mutants, and the complete list of the mutations detected is provided as Table S1. All but 2 of the 32 mutants not having mutations in ampD had mutations in dacB. A total of 28 different mutations were detected, and included deletions/insertions (9), nonsense mutations (7), and missense mutations (12). Many of the missense mutations occurred in sequences encoding highly conserved motifs, including the catalytic serine, at position 72 in P. aeruginosa (Figure S1, Table S1).
###end p 19
###begin p 20
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dacB</italic>
###xml 101 105 98 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dacB</italic>
###xml 157 164 150 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000353-t001">Table 1</xref>
###xml 186 190 179 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dacB</italic>
###xml 285 289 278 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dacB</italic>
###xml 354 358 344 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampC</italic>
In order to further confirm the role of dacB mutations in beta-lactam resistance, we constructed the dacB knockout mutant of PAO1 (PADeltadacB). As shown in Table 1, the inactivation of dacB in PAO1 yielded an almost identical phenotype to that documented in the ceftazidime-resistant dacB spontaneous mutants, with high level beta-lactam resistance and ampC overexpression. Therefore, it is for the first time demonstrated that the inactivation of a particular PBP (which are supposed to be antibiotic targets) produces high-level beta-lactam resistance.
###end p 20
###begin title 21
###xml 49 53 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampC</italic>
###xml 58 62 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creD</italic>
Susceptibility to beta-lactams and expression of ampC and creD genes in the studied mutants.
###end title 21
###begin p 22
###xml 44 48 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampC</italic>
###xml 84 88 76 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampR</italic>
###xml 124 128 112 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 164 168 148 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampE</italic>
###xml 205 214 185 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD-ampE</italic>
###xml 256 260 232 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 269 273 245 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 274 280 250 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampDh2</italic>
###xml 281 287 257 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampDh3</italic>
###xml 331 335 303 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampR</italic>
###xml 384 388 348 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dacB</italic>
###xml 443 451 407 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 491 495 451 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampC</italic>
###xml 531 535 487 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampR</italic>
###xml 571 575 523 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 611 615 559 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampE</italic>
###xml 662 669 610 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 739 743 687 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dacB</italic>
###xml 759 764 703 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creBC</italic>
###xml 811 816 751 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creBC</italic>
###xml 872 877 804 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creBC</italic>
###xml 917 922 845 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creBC</italic>
###xml 961 965 885 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creD</italic>
PAO1, wild-type reference strain; PADeltaC, ampC knockout mutant of PAO1; PADeltaR, ampR knockout mutant of PAO1; PADeltaD, ampD knockout mutant of PAO1; PADeltaE, ampE knockout mutant of PAO1; PADeltaDE, ampD-ampE knockout mutant of PAO1; PADeltaDDh2Dh3, ampD triple (ampD-ampDh2-ampDh3) knockout mutant of PAO1; PADeltaDDh2Dh3R, ampR knockout mutant of PADeltaDDh2Dh3; PADeltadacB, dacB knockout mutant of PAO1; 1A1 (DacB W273X), DacB W273X in vitro spontaneous mutant of PAO1; 1A1DeltaC, ampC knockout mutant of 1A1; 1A1DeltaR, ampR knockout mutant of 1A1; 1A1DeltaD, ampD knockout mutant of 1A1; 1A1DeltaE, ampE knockout mutant of 1A1;2A2 (DacB frameshift), in vivo spontaneous mutant of PAO1 containing a deletion of nts 1074-1078 in dacB; PADeltacreBC, creBC knockout mutant of PAO1; PADeltaDDh2Dh3creBC, creBC knockout mutant of PADeltaDDh2Dh3creBC; 1A1DeltacreBC, creBC knockout mutant of 1A1; 2A2DeltacreBC, creBC knockout mutant of 2A2; 1A1DeltacreD, creD knockout mutant of 1A1.
###end p 22
###begin p 23
CAZ, ceftazidime; CEP, cefepime; PIP, piperacillin; PIP/TZ, piperacillin-tazobactam; ATM, aztreonam; IMP, imipenem.
###end p 23
###begin p 24
Clinical Laboratory Standards Institute (CLSI) susceptibility breakpoints: CAZ, CEP, and ATM</=8 microg/ml; PIP and PIP/TZ</=64 microg/ml; IMP</=4 microg/ml.
###end p 24
###begin p 25
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampC</italic>
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creD</italic>
Relative amount of ampC or creD mRNA compared to PAO1 basal level+/-standard deviation. Induction experiments were carried out with 50 microg/ml cefoxitin.
###end p 25
###begin p 26
NA, not applicable; ND, not determined.
###end p 26
###begin title 27
###xml 12 25 12 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 12 25 <span type="species:ncbi:287">P. aeruginosa</span>
Mutation of P. aeruginosa PBP4 determines an AmpR-dependent overexpression of the beta-lactamase AmpC
###end title 27
###begin p 28
###xml 131 135 128 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampC</italic>
###xml 137 141 134 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampR</italic>
###xml 179 183 176 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 217 221 214 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampE</italic>
###xml 259 264 256 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampDE</italic>
###xml 353 357 350 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Honore2">[23]</xref>
###xml 403 411 400 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 483 490 480 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000353-t001">Table 1</xref>
###xml 512 516 509 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampC</italic>
###xml 702 706 696 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampR</italic>
###xml 753 757 747 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampC</italic>
###xml 947 951 941 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Ghosh1">[17]</xref>
###xml 988 992 982 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampC</italic>
###xml 1018 1022 1012 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dacB</italic>
###xml 1064 1068 1058 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 1261 1265 1255 1259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Jacobs1">[24]</xref>
###xml 1333 1340 1327 1334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1500 1504 1494 1498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Sanders1">[25]</xref>
###xml 1333 1340 <span type="species:ncbi:562">E. coli</span>
In order to understand the role of PBP4 mutation in beta-lactam resistance and upregulation of AmpC expression, we constructed the ampC, ampR (transcriptional regulator of AmpC), ampD (negative regulator of AmpC) and ampE (second component of the bicistronic ampDE operon, encodes an inner membrane-bound sensory transducer that modulates AmpD activity [23]), knockout mutants of strain 1A1 (DacB W273X in vitro spontaneous mutant of PAO1) and of strain PAO1 as control. As shown in Table 1, the inactivation of ampC completely restored ceftazidime susceptibility in 1A1, showing that the overexpression of the beta-lactamase is essential for the resistance phenotype. Furthermore, the inactivation of ampR restored ceftazidime susceptibility and basal ampC expression levels, thus demonstrating that the effect of PBP4 mutation requires a functional AmpR. Therefore, considering that PBP4 has been shown to be involved in peptidoglycan recycling [17] it seems reasonable to believe that ampC overexpression driven by dacB inactivation, as occurs in the classical ampD mutation pathway, should be consequence of the qualitative or quantitative modification of muropeptides, that are the effector molecules for AmpC induction through their interaction with AmpR [24]. Our results are also consistent with previous observations in the E. coli model, in which the strongest AmpC inducers (such as imipenem) were shown to be potent PBP4 inhibitors, suggesting a role of this PBP in the induction process [25].
###end p 28
###begin p 29
###xml 125 129 125 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 161 165 161 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampC</italic>
###xml 212 219 212 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000353-t001">Table 1</xref>
###xml 261 265 261 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampE</italic>
###xml 285 289 285 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 375 379 375 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampC</italic>
###xml 425 429 425 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dacB</italic>
###xml 482 487 482 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampDE</italic>
###xml 520 524 520 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dacB</italic>
###xml 651 656 651 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampDE</italic>
###xml 700 707 700 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000353-t002">Table 2</xref>
###xml 738 742 738 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dacB</italic>
###xml 805 809 805 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dacB</italic>
###xml 818 822 818 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 832 839 832 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000353-t002">Table 2</xref>
###xml 914 918 914 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampC</italic>
Additionally, we show that the AmpDE pathway of AmpC repression is functional in the PBP4 mutants, since the inactivation of ampD dramatically increased further ampC expression and ceftazidime resistance in 1A1 (Table 1). Furthermore, while the inactivation of ampE in PAO1 (or in its ampD mutant) did not produce significant effects, it also determined a marked increase of ampC expression and ceftazidime resistance in the dacB mutant.These results suggest that both genes of the ampDE operon play a major role in the dacB mutant background. This conclusion is further supported by the positive complementation of the PBP4 mutants with the complete ampDE operon expressed from a multicopy plasmid (Table 2). Moreover, the expression of dacB from a multicopy plasmid (pUCPdB) also complemented both, the dacB and the ampD mutants (Table 2). Therefore, these results show that PBP4 and AmpDE are parallel synergic ampC regulatory pathways (a defect in one of them can be complemented by increasing the amount of the other), both ultimately relying on a functional AmpR.
###end p 29
###begin title 30
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 64 68 64 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dacB</italic>
Results of the complementation experiments of the PAO1 ampD and dacB mutants with different plasmids.
###end title 30
###begin p 31
###xml 44 48 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 87 91 79 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dacB</italic>
PAO1, wild-type reference strain; PADeltaD, ampD knockout mutant of PAO1; PADeltadacB, dacB (PBP4) knockout mutant of PAO1.
###end p 31
###begin p 32
###xml 50 54 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampC</italic>
###xml 191 195 188 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 312 319 309 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000353-t001">Table 1</xref>
###xml 459 463 456 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 473 486 470 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 488 492 485 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 535 541 532 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampDh2</italic>
###xml 546 552 543 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampDh3</italic>
###xml 552 556 549 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Juan2">[26]</xref>
###xml 599 603 596 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampC</italic>
###xml 616 623 613 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000353-t001">Table 1</xref>
###xml 716 720 713 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Moya1">[27]</xref>
###xml 721 725 718 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Schmidtke1">[28]</xref>
###xml 850 854 847 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Moya1">[27]</xref>
###xml 874 881 871 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 952 956 949 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dacB</italic>
###xml 1108 1112 1105 1109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 1121 1125 1118 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Moya1">[27]</xref>
###xml 1157 1161 1154 1158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 1201 1214 1198 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 473 486 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 883 889 <span type="species:ncbi:10090">murine</span>
###xml 1201 1214 <span type="species:ncbi:287">P. aeruginosa</span>
While both pathways have a very similar effect on ampC expression, PBP4 mutation confers high level (clinical) beta-lactam resistance (i.e. resistant according to current breakpoints), while ampD inactivation confers only moderate resistance (i.e. still susceptible according to current resistance breakpoints) (Table 1). In fact, the resistance level conferred by PBP4 mutation is more similar to that conferred by the simultaneous inactivation of the three ampD genes of P. aeruginosa (ampD plus the two additional homologous genes, ampDh2 and ampDh3[26]), that produces a much higher increase in ampC expression (Table 1). Nevertheless, this mechanism of high-level resistance is not found among clinical strains [27],[28], because it requires the acquisition of several mutations and because it causes a marked reduction of fitness and virulence [27]. Here we show that in vivo (murine systemic infection model) fitness is not affected in the PAO1 dacB mutant, as shown by the competition index (CI) of 0.92, in sharp contrast to the previously documented CIs of less than 0.01 for the double and triple ampD mutants [27]. Therefore, in contrast to the ampD inactivation pathway, PBP4 mutation in P. aeruginosa is a very efficient one-step trigger of high level beta-lactam resistance mechanism of potentially enormous clinical relevance.
###end p 32
###begin title 33
###xml 12 25 12 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 12 25 <span type="species:ncbi:287">P. aeruginosa</span>
Mutation of P. aeruginosa PBP4 specifically triggers the activation of the CreBC two-component regulator, which in turn plays a major role in resistance
###end title 33
###begin p 34
###xml 217 230 217 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 260 264 260 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampC</italic>
###xml 421 425 421 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creD</italic>
###xml 481 485 481 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creD</italic>
###xml 644 651 644 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 724 728 724 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Avison1">[18]</xref>
###xml 775 784 775 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aeromonas</italic>
###xml 903 907 900 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Niumsup1">[29]</xref>
###xml 908 912 905 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Alksne1">[31]</xref>
###xml 953 957 950 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creD</italic>
###xml 1126 1133 1123 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000353-t001">Table 1</xref>
###xml 1176 1183 1173 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1188 1196 1185 1193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1216 1220 1213 1217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creD</italic>
###xml 1339 1343 1336 1340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dacB</italic>
###xml 1381 1385 1378 1382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creD</italic>
###xml 1402 1409 1399 1406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000353-t001">Table 1</xref>
###xml 1426 1430 1423 1427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creD</italic>
###xml 1586 1590 1583 1587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 1600 1607 1597 1604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000353-t001">Table 1</xref>
###xml 1625 1629 1622 1626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creD</italic>
###xml 1732 1739 1726 1733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000353-t001">Table 1</xref>
###xml 1755 1759 1749 1753 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creD</italic>
###xml 1806 1810 1800 1804 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 1937 1944 1931 1938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000353-t001">Table 1</xref>
###xml 2079 2083 2073 2077 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampC</italic>
###xml 217 230 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 644 651 <span type="species:ncbi:562">E. coli</span>
In order to explore further the effects of PBP4 mutation, we performed a whole-genome analysis of gene expression in two selected mutant strains (1A1 and 2A2) compared to wild-type PAO1, using the Affymetrix GeneChip P. aeruginosa genome array. In addition to ampC (and co-transcribed PA4111), which obviously was upregulated, only one further gene showed a significantly (>2-fold change) modified expression. This gene, creD, was upregulated in both mutants analyzed (not shown). creD encodes an inner membrane protein of yet unknown function that is regulated by the CreBC two-component regulator. The CreBC system has been deeply studied in E. coli, and it is shown to be a global regulator involved in metabolic control [18]. Interestingly, the homolog of this system in Aeromonas Spp. (designated BlrAB) has been shown to play a role in the regulation of beta-lactamase expression in these species [29]-[31]. As first approach, we analyzed whether creD overexpression was a signature feature of the PBP4 mutants. Indeed, real time RT-PCR experiments confirmed the overexpression of this gene in the two selected mutants (Table 1) as well as in the complete collection of in vivo and in vitro PBP4 mutants, with creD mRNA levels ranging from 25 to 60-fold higher than those of wild-type PAO1 (not shown). Moreover, the inactivation of dacB in wild-type PAO1 produced a similar creD overexpression (Table 1). The effect on creD expression seemed to be specific for the PBP4 mutants, rather than a direct consequence of AmpC overexpression, since this gene was not upregulated in the ampD mutants (Table 1). Interestingly, creD expression in wild-type PAO1 was found to be highly inducible by beta-lactamase inducers (cefoxitin) (Table 1). Furthermore, creD inducibility was significantly reduced in the ampD mutants and the reduction in expression was dependent on a functional AmpR, since its inactivation restored the inducibility (Table 1). Overall, these results suggested a link between the CreBC regulator, PBP4 mutations, and the components of the regulatory system of ampC expression.
###end p 34
###begin p 35
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creB</italic>
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creC</italic>
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creD</italic>
###xml 410 414 407 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dacB</italic>
###xml 480 484 477 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampC</italic>
###xml 489 493 486 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creD</italic>
###xml 541 545 538 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dacB</italic>
The complete creB, creC and creD genes, as well as their promoter regions, were fully sequenced in 1A1, 2A2 and five additional randomly selected mutants from the collection. The absence of mutations supported further the notion that the mutations in PBP4 are solely responsible for the complete beta-lactam resistance response. The single mutation hypothesis is definitively confirmed by the fact that direct dacB inactivation produces the same phenotype (i.e. the same MICs and ampC and creD expression levels) observed in the spontaneous dacB mutants.
###end p 35
###begin p 36
###xml 93 98 90 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creBC</italic>
###xml 103 107 100 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creD</italic>
###xml 203 207 200 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 264 269 261 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creBC</italic>
###xml 323 327 320 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creD</italic>
###xml 507 514 501 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000353-t001">Table 1</xref>
###xml 628 633 619 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creBC</italic>
###xml 675 679 666 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 689 696 680 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000353-t001">Table 1</xref>
###xml 844 848 835 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creD</italic>
###xml 1005 1009 993 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creD</italic>
###xml 1128 1135 1116 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000353-t001">Table 1</xref>
###xml 1195 1199 1183 1187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 1242 1246 1230 1234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampC</italic>
###xml 1451 1455 1439 1443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 1464 1471 1452 1459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000353-t001">Table 1</xref>
###xml 1830 1832 1811 1813 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 1913 1916 1894 1897 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;11</sup>
###xml 2117 2130 2091 2104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 2117 2130 <span type="species:ncbi:287">P. aeruginosa</span>
To gain insights into the role of the CreBC system in beta-lactam resistance, we constructed creBC and creD knockout mutants of the PBP4 mutants 1A1 and 2A2, as well as of PAO1 and its single and triple ampD mutants as controls. Interestingly, the inactivation of creBC in the PBP4 mutants (1A1 and 2A2) not only decreased creD expression back to wild-type levels, but also drastically decreased beta-lactam MICs, leaving them well within the susceptible (treatable) range according to current breakpoints (Table 1). Furthermore, the effect was specific to the PBP4 mutants, since beta-lactam susceptibility was not affected by creBC inactivation in wild-type PAO1 or in its ampD mutants (Table 1). Overall, these results strongly suggest that PBP4 mutations specifically trigger the activation of the CreBC two-component regulator, leading to creD upregulation and beta-lactam resistance. Nevertheless, CreD seems not to be the only CreBC-dependent driver of resistance, since the direct inactivation of creD in the PBP4 mutants decreased resistance slightly, but did not give the drastic reduction seen on CreBC inactivation (Table 1). The extra resistance of the PBP4 mutants compared to the ampD mutant (despite showing similar levels of ampC expression) is therefore apparently driven by the specific activation of the CreBC system in the PBP4 mutants. Indeed, the resistance level of 1A1 after CreBC inactivation was more similar to that of the ampD mutant (Table 1). Further evidence showing that the CreBC system is a key component in one-step high level beta-lactam resistance development was provided by mutation rates experiments. While high level ceftazidime resistant mutants were readily selected from PAO1 wild-type strain [mutation rate to ceftazidime (at breakpoint concentration, 16 microg/ml) resistance of 3x10-8 mutants per cell division], mutation rates were below the detection limit (<1x10-11) for its CreBC knockout mutant (PADeltaCreBC), consistently with the interpretation that a functional CreBC system is required for one-step high level (clinical) beta-lactam resistance development in P. aeruginosa.
###end p 36
###begin p 37
###xml 79 88 79 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aeromonas</italic>
###xml 161 165 161 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampC</italic>
###xml 284 288 280 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampC</italic>
###xml 317 324 313 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000353-t001">Table 1</xref>
###xml 735 739 725 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creD</italic>
###xml 1129 1142 1116 1129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 1185 1194 1172 1181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aeromonas</italic>
###xml 1264 1271 1248 1255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1317 1321 1301 1305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Avison1">[18]</xref>
###xml 1323 1327 1307 1311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Niumsup1">[29]</xref>
###xml 1328 1332 1312 1316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Alksne1">[31]</xref>
###xml 1129 1142 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 1264 1271 <span type="species:ncbi:562">E. coli</span>
Nevertheless, in contrast to the previous experiences with the BlrAB system in Aeromonas Spp., CreBC mediated resistance was not directly driven by an effect on ampC expression, since 1A1DeltaCreBC (despite showing a drastic reduction of resistance) had similar (still overexpressed) ampC levels than the parent 1A1 (Table 1). Moreover, beta-lactamase activity was also similar (data not shown), showing that apparently the effect is neither produced by posttranscriptional modification of AmpC. Therefore, although we demonstrate that mutation of PBP4 specifically activates the CreBC two-component regulator, and that this event plays a major role in beta-lactam resistance, the underlying mechanism is still uncertain. Despite only creD showed a modified expression greater 2-fold in the transcriptome analysis, even small modifications of expression of genes involved in outer membrane permeability, antibiotic efflux or general metabolism could significantly enhance the effect of AmpC overexpression and thus beta-lactam resistance. In any case, our findings indicate that the nomenclature for this two-component system in P. aeruginosa should be changed to follow that used for Aeromonas Spp. (Blr, standing for beta-lactam resistance) and not that used in E. coli (Cre, standing for carbon-source responsive) [18], [29]-[31].
###end p 37
###begin p 38
###xml 0 8 0 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000353-g002">Figure 2</xref>
###xml 45 63 45 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa ampC</italic>
###xml 45 58 <span type="species:ncbi:287">P. aeruginosa</span>
Figure 2 summarizes the current knowledge on P. aeruginosa ampC regulation, peptidoglycan recycling, and the described similarities and differences of the beta-lactam resistance response driven by AmpD inactivation or PBP4 mutation.
###end p 38
###begin title 39
###xml 50 63 50 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 50 63 <span type="species:ncbi:287">P. aeruginosa</span>
Schematic representation of the regulation of the P. aeruginosa chromosomal beta-lactamase AmpC and peptidoglycan recycling under different conditions.
###end title 39
###begin p 40
###xml 498 511 492 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 1022 1026 1013 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampC</italic>
###xml 1837 1841 1822 1826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampC</italic>
###xml 2050 2054 2032 2036 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampC</italic>
###xml 2579 2583 2558 2562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampC</italic>
###xml 2726 2730 2705 2709 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampC</italic>
###xml 201 206 <span type="species:ncbi:42554">tetra</span>
###xml 498 511 <span type="species:ncbi:287">P. aeruginosa</span>
(A) Wild-type strain in the absence of beta-lactams. During regular bacterial growth, the peptidoglycan degradation products, MurNac-peptides [N-acetylglucosaminyl-1,6-anhydro- N-acetylmuramyl-tri (or tetra) peptides], are generated in the periplasm through the activity of PBP4 and several other enzymes. These products are then internalized through the permease AmpG, and processed in the cytoplasm by the beta-N-acetylglucosaminidase NagZ and the N-acetyl-anhydromuramyl-L-alanine amidase AmpD. P. aeruginosa has two additional AmpD proteins, AmpDh2 that it is apparently located in the outer membrane and AmpDh3 that is still of unknown location. The generated tripeptides are then incorporated to the murein biosynthesis pathway to yield the UDP-MurNac-pentapeptides that will be exported to the periplasm and incorporated to the peptidoglycan, to complete the recycling process. In the absence of beta-lactam antibiotics, these UDP-MurNac-pentapeptides interact with AmpR, which functions as a negative regulator of ampC expression. (B) Growth of wild-type strain in the presence AmpC inducer beta-lactams. During growth in the presence of certain beta-lactams (AmpC inducers), such as cefoxitin or imipenem, AmpC is produced at high levels, conferring natural (intrinsic) resistance to the antibiotic, provided it is a good substrate for the enzyme (as occurs for cefoxitin but not for imipenem). The exact mechanism responsible for the induction of the expression of AmpC in the presence of these antibiotics is still not fully understood. One of the components of the induction process is apparently the saturation of AmpD, due to the enhanced generation of its substrate (MurNac-tripeptides). The accumulated MurNAc-tripeptides are thought to displace the UDP-MurNAc-pentapeptides from AmpR, converting it into an activator of ampC transcription. Our results, and other previous indirect evidences, suggest that the inhibition of PBP4 by these beta-lactam antibiotics (known to be the most potent PBP4 inhibitors) plays a major role in the ampC induction process, and determines the activation of the CreBC (BlrAB) two-component regulator. The exact function of the signal transducer AmpE, located in the inner membrane, still needs to be elucidated, but apparently interacts with both AmpD and PBP4. (C) Growth of the AmpD and/or PBP4 mutants in the presence of AmpC non-inducer beta-lactams (most antipseudomonal cephalosporins and penicillins, such as ceftazidime or piperacillin, respectively). The inactivation of PBP4 or AmpD produces a very similar constitutive ampC overexpression. Both mechanisms ultimately relay in the activation of AmpR, which changes its activity from negative to positive regulator of ampC expression. Independently of the mechanism, AmpC overexpression itself is shown to confer only moderate (low-level) acquired resistance to non-inducer beta-lactams. Additionally, the inactivation of PBP4 specifically activates the CreBC (BlrAB) system, which drives, in conjunction with the AmpC overexpression, the high-level beta-lactam resistance response.
###end p 40
###begin title 41
Role of PBP4 mutation in the clinical setting
###end title 41
###begin p 42
###xml 92 100 92 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 105 112 105 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 234 237 234 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Juan1">[6]</xref>
###xml 412 425 412 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 713 717 710 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 729 732 726 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Juan1">[6]</xref>
###xml 746 753 743 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000353-t003">Table 3</xref>
###xml 815 819 812 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dacB</italic>
###xml 1053 1060 1050 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1070 1078 1067 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000353.s001">Table S1</xref>
###xml 1136 1140 1133 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Kishida1">[16]</xref>
###xml 1188 1196 1185 1193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1201 1208 1198 1205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1261 1265 1258 1262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creD</italic>
###xml 1340 1347 1337 1344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000353-t003">Table 3</xref>
###xml 1370 1375 1367 1372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creBC</italic>
###xml 1465 1472 1462 1469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000353-t003">Table 3</xref>
###xml 1512 1516 1509 1513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creD</italic>
###xml 1592 1596 1589 1593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 146 151 <span type="species:ncbi:9606">human</span>
###xml 378 386 <span type="species:ncbi:9606">patients</span>
###xml 392 400 <span type="species:ncbi:9606">patients</span>
###xml 412 425 <span type="species:ncbi:287">P. aeruginosa</span>
To find out whether PBP4 mutations and the linked CreBCD mediated resistance documented for in vitro and in vivo mutants occurred also in natural human infections, we investigated a previously described collection of clinical strains [6]. This collection included 10 isogenic pairs of ceftazidime susceptible and resistant clinical isolates obtained from 10 Intensive Care Unit patients. All patients had severe P. aeruginosa infections that were treated with beta-lactams, experiencing therapy failure due to resistance development. In all cases, the subsequent ceftazidime resistant isolate showed AmpC hyperproduction, but only in four of them could the resistance phenotype be attributed to known mechanisms (ampD mutations) [6]. As shown in Table 3, all 6 remaining ceftazidime isolates contained mutations in dacB (not present in the preceding isogenic susceptible isolate). Interestingly, two of the isolates (despite them being genetically distinct) have sustained the same PBP4 mutation (T428P); this same mutation was found in one of the PAO1 in vivo mutants (Table S1) and involves a conserved residue close to the KTG motif [16]. Furthermore, consistent with the findings for in vitro and in vivo mutants, all six natural PBP4 mutants overexpressed creD (2.8-38 fold higher expression than their respective wild-type isolates) (Table 3). The inactivation of creBC significantly reduced ceftazidime resistance in all but one of the natural PBP4 mutants (Table 3). On the other hand, the expression of creD was not modified in the four clinical strains containing only mutations in ampD (not shown).
###end p 42
###begin title 43
Characterization of beta-lactam resistant clinical isolates.
###end title 43
###begin p 44
CAZ, ceftazidime; PIP-TZ, piperacillin-tazobactam; IMP, imipenem; CEP, cefepime.
###end p 44
###begin p 45
###xml 124 127 124 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Juan1">[6]</xref>
Strains JSG1H9/JSG2A1 and OFC2H1/OFC2I4 additionally overexpressed the efflux pumps MexAB-OprM and MexEF-OprN, respectively [6].
###end p 45
###begin p 46
###xml 71 75 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 118 121 115 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Juan1">[6]</xref>
The information on antibiotic treatments, beta-lactamase activity, and ampD mutations was obtained from previous work [6].
###end p 46
###begin p 47
Fold increase of beta-lactamase activity in the ceftazidime-resistant isolate compared to its preceding clonally related susceptible isolate.
###end p 47
###begin p 48
###xml 161 165 161 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampR</italic>
###xml 169 178 169 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampC-ampR</italic>
Mutations detected in the ceftazidime-resistant isolates not present in the preceding isogenic susceptible isolates. None of the isolates contained mutations in ampR or ampC-ampR intergenic region.
###end p 48
###begin p 49
###xml 215 219 211 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dacB</italic>
Ceftazidime MIC (microg/ml) of: ceftazidime-susceptible isolates, subsequent ceftazidime-resistant clonally related isolates, ceftazidime-resistant isolates complemented with plasmid pUCPdB harbouring the wild-type dacB gene, and CreBC knockout mutants of the ceftazidime-resistant isolates.
###end p 49
###begin p 50
CreBC knockout mutants of this strain were not obtained after several attempts.
###end p 50
###begin p 51
###xml 29 33 29 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creD</italic>
p<0.05 for the comparison of creD expression in CAZ R - CAZ S pairs of sequential isolates.
###end p 51
###begin title 52
Concluding remarks
###end title 52
###begin p 53
###xml 6 19 6 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 167 171 164 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dacB</italic>
###xml 466 469 457 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Zapun1">[2]</xref>
###xml 578 582 569 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dacB</italic>
###xml 1277 1281 1256 1260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dacB</italic>
###xml 1283 1287 1262 1266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampC</italic>
###xml 1289 1293 1268 1272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampR</italic>
###xml 1299 1305 1278 1284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creBCD</italic>
###xml 1345 1352 1324 1331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1392 1396 1371 1375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampR</italic>
###xml 1428 1432 1407 1411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Honore1">[14]</xref>
###xml 6 19 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 1345 1352 <span type="species:ncbi:562">E. coli</span>
Using P. aeruginosa as a model organism, we have shown that the most prevalent mutations causing immediate onset of high level beta-lactam resistance are found in the dacB gene, encoding the nonessential PBP4. This is the first demonstration of the acquisition of beta-lactam resistance through such a mechanism. All the previous examples by which PBP-mediated resistance develops involve modified enzymes showing low affinity for beta-lactams (target modification) [2]. Even though inactivation of the classical AmpC negative regulator AmpD upregulates AmpC, only mutations in dacB confer high level (clinical) beta-lactam resistance. The inactivation of PBP4 is found to trigger an AmpR-dependent overproduction of the chromosomal beta-lactamase AmpC, and the specific activation of the CreBC (BlrAB) two-component regulator, which in turn plays a major role in the beta-lactam resistance response. This interplay between mutation of supposed antibiotic targets, production of antibiotic inactivating enzymes, and global regulators, is an unexpected layer of complexity of beta-lactam resistance biology, which provides new perspectives on potential antibiotic targets for the treatment of infectious diseases. Since all the components of the described resistance mechanism (dacB, ampC, ampR, and creBCD) are found in the genomes of many GNR (E. coli might be an example of exception since ampR is not present in this species [14]), the results presented here are expected to have broad implications for the development of new antimicrobial compounds. Particularly, the CreBCD system is envisaged as an attractive candidate target to develop molecules capable of reducing the development of resistance when used together with beta-lactam antibiotics.
###end p 53
###begin title 54
Materials and Methods
###end title 54
###begin title 55
Bacterial strains and plasmids
###end title 55
###begin p 56
###xml 100 108 100 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000353.s002">Table S2</xref>
###xml 133 137 133 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Plasencia1">[19]</xref>
###xml 242 250 242 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 285 292 285 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 518 522 514 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mutS</italic>
###xml 552 556 544 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mutS</italic>
###xml 622 625 614 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Juan1">[6]</xref>
###xml 785 798 777 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 358 363 <span type="species:ncbi:10090">mouse</span>
###xml 754 762 <span type="species:ncbi:9606">patients</span>
###xml 785 798 <span type="species:ncbi:287">P. aeruginosa</span>
A complete list of laboratory strains and plasmids used or constructed in this study is provided as Table S2. A previously described [19] collection of 36 independent ceftazidime resistant mutants was used. These mutants were obtained either in vitro (one-step spontaneous mutants) or in vivo (after 3 days of treatment with humanized ceftazidime regimen in mouse model of lung infection), at two ceftazidime concentrations (4 and 16 microg/ml), and from the wild-type strain PAO1 (normal mutation rate supply) or its mutS deficient derivative PAODeltamutS (high mutation rate supply). Additionally, a previously reported [6] collection of 10 isogenic pairs of ceftazidime susceptible and resistant clinical isolates obtained from 10 Intensive Care Unit patients suffering from severe P. aeruginosa infections was used.
###end p 56
###begin title 57
Construction of knockout mutants
###end title 57
###begin p 58
###xml 0 13 0 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 53 57 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 59 63 59 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampE</italic>
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampR</italic>
###xml 71 75 71 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampC</italic>
###xml 77 82 77 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creBC</italic>
###xml 84 88 84 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creD</italic>
###xml 93 97 93 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dacB</italic>
###xml 125 132 125 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre-lox</italic>
###xml 201 205 201 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Qune1">[32]</xref>
###xml 270 278 270 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000353.s003">Table S3</xref>
###xml 503 510 503 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 513 514 513 514 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 605 608 601 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox</italic>
###xml 649 653 645 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">aac1</italic>
###xml 703 706 699 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox</italic>
###xml 860 867 856 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 870 871 866 867 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1021 1028 1009 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1696 1699 1664 1667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cre</italic>
###xml 0 13 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 503 510 <span type="species:ncbi:562">E. coli</span>
###xml 860 867 <span type="species:ncbi:562">E. coli</span>
###xml 1021 1028 <span type="species:ncbi:562">E. coli</span>
P. aeruginosa single or multiple knockout mutants in ampD, ampE, ampR, ampC, creBC, creD, or dacB were constructed using the Cre-lox system for gene deletion and antibiotic resistance marker recycling [32]. Upstream and downstream PCR products (primers used provided as Table S3) of each gene were digested with either BamHI or EcoRI and HindIII and cloned by a three way ligation into pEX100Tlink deleted for the HindIII site and opened by EcoRI and BamHI. The resulting plasmids were transformed into E. coli XL1Blue strain and transformants were selected in 30 microg/ml ampicillin LB agar plates. The lox flanked gentamicin resistance cassette (aac1) obtained by HindIII restriction of plasmid pUCGmlox was cloned into the single site for this enzyme formed by the ligation of the two flanking fragments. The resulting plasmids were again transformed into E. coli XL1Blue strain and transformants were selected in 30 microg/ml ampicillin-5 microg/ml gentamicin LB agar plates. Plasmids were then transformed into the E. coli S17-1 helper strain. Knockout mutants were generated by conjugation followed by selection of double recombinants using 5% sucrose-1 microg/ml cefotaxime-30 microg/ml gentamicin LB agar plates. Double recombinants were checked first screening for carbellicin (200 microg/ml) susceptibility and afterwards by PCR amplification and sequencing. For the recycling of the gentamicin resistance cassettes, plasmid pCM157 was electroporated into the different mutants. Transformants were selected in 250 microg/ml tetracycline LB agar plates. One transformant for each mutant was grown overnight in 250 microg/ml tetracycline LB broth in order to allow the expression of the cre recombinase. Plasmid pCM157 was then cured from the strains by successive passages on LB broth. Selected colonies were then screened for tetracycline (250 microg/ml) and gentamicin (30 microg/ml) susceptibility and checked by PCR amplification and DNA sequencing.
###end p 58
###begin title 59
PCR, sequencing, and quantification of gene expression
###end title 59
###begin p 60
###xml 114 118 111 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 120 124 117 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampE</italic>
###xml 126 130 123 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampR</italic>
###xml 132 138 129 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampDh2</italic>
###xml 140 146 137 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampDh3</italic>
###xml 148 152 145 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creB</italic>
###xml 154 158 151 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creC</italic>
###xml 160 164 157 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creD</italic>
###xml 169 173 166 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dacB</italic>
###xml 230 238 227 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000353.s003">Table S3</xref>
###xml 626 630 623 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Stover1">[33]</xref>
###xml 631 635 628 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Winsor1">[34]</xref>
In order to explore the beta-lactam resistance mechanisms in the above described collection of bacterial strains, ampD, ampE, ampR, ampDh2, ampDh3, creB, creC, creD and dacB genes were amplified by PCR, using primers described in Table S3, and fully sequenced. All mutations detected were checked by sequencing a fresh independent PCR product. Sequencing reactions were performed with the BigDye Terminator Kit (PE Applied Biosystems, Foster City, Calif.) and sequences were analyzed on an ABI prism 3100 DNA sequencer (PE Applied Biosystems). Resulting sequences were then compared () with those of the wild-type PAO1 strain [33],[34].
###end p 60
###begin p 61
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampC</italic>
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampE</italic>
###xml 46 52 46 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampDh2</italic>
###xml 54 60 54 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampDh3</italic>
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creD</italic>
###xml 808 816 790 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000353.s003">Table S3</xref>
###xml 848 852 830 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampC</italic>
###xml 854 858 836 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 860 864 842 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampE</italic>
###xml 866 872 848 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampDh2</italic>
###xml 874 880 856 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampDh3</italic>
###xml 882 886 864 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">creD</italic>
###xml 892 896 874 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rpsL</italic>
The levels of expression of ampC, ampD, ampE, ampDh2, ampDh3 and creD were determined by real time RT-PCR with and without cefoxitin induction. Total RNA from logarithmic-phase-grown cultures (grown with and without 50 microg/ml cefoxitin) was obtained with the RNeasy Mini Kit (QIAGEN, Hilden, Germany) and treated with 2 U of TURBO DNase (Ambion) for 30 min at 37degreesC to remove contaminating DNA. The reaction was stopped by the addition of 5 microl of DNase inactivation reagent and the samples were adjusted to a final concentration of 50 ng/microl. A 500 ng sample of purified RNA was then used for one-step reverse transcription and real-time PCR amplification using the QuantiTect SYBR Green RT-PCR Kit (QIAGEN, Hilden, Germany) in a SmartCycler II (Cepheid, Sunnyvale, CA). The primers listed in Table S3 were used for amplification of ampC, ampD, ampE, ampDh2, ampDh3, creD, and rpsL (used as reference to normalize the relative amount of mRNA). In all cases, the mean values of relative mRNA expression obtained in at least three independent duplicate experiments were considered.
###end p 61
###begin title 62
Susceptibility testing, quantification of beta-lactamase activity, complementation studies, estimation of mutation rates, and fitness experiments
###end title 62
###begin p 63
###xml 549 552 546 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Juan1">[6]</xref>
###xml 944 947 931 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Juan1">[6]</xref>
###xml 999 1003 986 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 1053 1058 1040 1045 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampDE</italic>
###xml 1273 1277 1257 1261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 1294 1298 1278 1282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampE</italic>
###xml 1404 1408 1388 1392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dacB</italic>
###xml 1918 1926 1894 1902 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1943 1950 1919 1926 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 2069 2073 2045 2049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Moya1">[27]</xref>
###xml 1952 1958 <span type="species:ncbi:10090">murine</span>
Minimal inhibitory concentrations (MICs) for ceftazidime, cefepime, ticarcillin, piperacillin, piperacillin/tazobactam, aztreonam, imipenem, meropenem ciprofloxacin, tobramycin, tetracycline, chloramphenicol and colistin were determined in Muller-Hinton (MH) agar plates using E-test strips (AB Biodisk, Sweden) following the manufacturers recommendations. beta-lactamase specific activity (nanomoles of nitrocefin hydrolyzed per minute per milligram of protein) was determined spectrophotometrically on crude sonic extracts as previously described [6]. To determine the beta-lactamase specific activity after induction, before the preparation of the crude sonic extracts, the strains were grown in the presence of 50 microg/ml cefoxitin for 3 h. In all cases, the mean beta-lactamase activity values obtained in three independent experiments were considered. Complementation experiments were performed following previously described protocols [6]. Briefly, plasmids pUCPAD (harboring the wild-type ampD gene), pUCPADE (harboring the complete wild-type ampDE operon) or pUCP24 (cloning vector) were electroporated into the different beta-lactam resistant strains or PAO1 (as control). Additionally, plasmids pUCPADE2A1, pUCPADE1C5 or pUCPADE2C2 containing a non functional ampD and a wild-type ampE were electroporated in selected mutants. Finally, complementation experiments using the cloned wild-type dacB gene (pUCPdB) were also performed in selected strains. Transformants were selected in 50 microg/ml gentamicin LB agar plates. Complementation was considered positive when the MICs of ceftazidime for the transformants were at least 3 two-fold dilutions lower than those of the parent strains. The rates of mutation to high level (16 microg/ml) ceftazidime resistance were estimated following previously described protocols (19). To determine the effect on bacterial fitness of particular resistance mutations, in vitro (LB growth) and in vivo (murine model of systemic infection) competition experiments were performed following previously described procedures [27]. Median Competition Indexes (CIs), defined as the mutant/wild-type ratio, were calculated from at least 8 independent experiments.
###end p 63
###begin title 64
Analysis of whole-genome gene expression
###end title 64
###begin p 65
###xml 831 844 809 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 946 950 924 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Blazquez1">[35]</xref>
###xml 831 844 <span type="species:ncbi:287">P. aeruginosa</span>
Three independent replicates of PAO1 and of two selected ceftazidime resistant mutants (1A1 and 2A2) were grown in 10 ml of LB broth in a 50-ml baffled flask vigorously shaken at 37degreesC to an optical density at 600 nm (OD600) of 1. The cells were collected by centrifugation (8,000 g for 5 min at 4degreesC) and total RNA was isolated using the RNeasy minikit (QIAGEN) following the manufacturer's instructions. RNA was dissolved in water and treated with 2 U of TURBO DNase (Ambion) for 30 min at 37degreesC to remove contaminating DNA. The reaction was stopped by the addition of 5 microl of DNase inactivation reagent. Ten micrograms of total RNA were checked by running on an agarose gel prior to cDNA synthesis. cDNA synthesis, fragmentation, labeling and hybridization were performed according to the Affymetrix GeneChip P. aeruginosa genome array expression analysis protocol. Expression analysis was performed as described previously [35]. Only transcripts showing higher than two-fold increases or decreases were considered as differentially expressed. In all cases the PPDE (posterior probability for differential expression) was between 0.999 and 1.
###end p 65
###begin title 66
Whole-genome analysis to detect the mutations involved in ceftazidime resistance
###end title 66
###begin p 67
###xml 356 369 353 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 369 373 366 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Dtsch1">[20]</xref>
###xml 1049 1053 1028 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000353-Dtsch1">[20]</xref>
###xml 356 369 <span type="species:ncbi:287">P. aeruginosa</span>
In order to detect the presence of mutations in genes yet unknown to be involved in beta-lactam resistance, a whole-genome analysis approach was followed. For this purpose, four ceftazidime resistant mutants were analyzed and compared with wild-type PAO1 using a recently described microarray for the discovery of single nucleotide polymorphisms (SNPs) in P. aeruginosa[20]. Cultures were grown in brain-heart infusion (BHI) medium for 12 h at 37degreesC in shaking glass flasks at 180 rpm and genomic DNA was isolated using the DNeasy Blood & Tissue Kit (Qiagen). Cell lysates were treated with RNase I (Qiagen) to prevent accidental carryover of RNA to the microarray. Genomic DNA was partially digested with DNase I (Amersham Biosciences, Piscataway, NJ) to a fragment size of approximately50-250 bp, confirmed by gel electrophoresis, and fragments were labeled at the 3'-ends with biotin-ddUTP (Roche Diagnostics, Indianapolis, IN) using Terminal deoxynucleotidyl transferase (Roche). Samples were hybridized to an identical lot of PATA1 arrays [20] for 16 hours at 50degreesC. After hybridization the microarrays were washed, stained with SA-PE and read using an Affymetrix GeneChip fluidic station and scanner according to Affymetrix standard protocols (Affymetrix, Santa Clara, CA). Analysis of microarray data was performed using the Affymetrix GCOS 1.4 to generate the raw data files (cel data). The raw data files were further analyzed using 'Tiling Analysis Software' (TAS) version 1.1 by Affymetrix.
###end p 67
###begin title 68
Supporting Information
###end title 68
###begin p 69
###xml 20 28 20 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 33 40 33 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Characterization of in vitro and in vivo ceftazidime-resistant mutants. The sequences corresponding to the signal peptides are shown in italics. SXXK, SXN, and KTG motifs are shown within boxes and the delimitations of the three domains are indicated with arrows. Asterisks, colons, and periods indicate identical, conserved, and semiconserved residues, respectively.
###end p 69
###begin p 70
(0.06 MB PDF)
###end p 70
###begin p 71
Click here for additional data file.
###end p 71
###begin p 72
Strains and plasmids used or constructed in this study
###end p 72
###begin p 73
(0.06 MB PDF)
###end p 73
###begin p 74
Click here for additional data file.
###end p 74
###begin p 75
Primers used in this work
###end p 75
###begin p 76
(0.04 MB PDF)
###end p 76
###begin p 77
Click here for additional data file.
###end p 77
###begin p 78
###xml 57 64 57 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 73 86 73 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 57 64 <span type="species:ncbi:562">E. coli</span>
###xml 73 91 <span type="species:ncbi:208964">P. aeruginosa PAO1</span>
Clustal W 2.0.8 multiple-sequence alignment of DacB from E. coli K12 and P. aeruginosa PAO1
###end p 78
###begin p 79
(0.03 MB PDF)
###end p 79
###begin p 80
Click here for additional data file.
###end p 80
###begin p 81
We are grateful to Professor Jeremy Tame of Yokohama City University for highly constructive comments and suggestions. We also thank J. L. Perez, Chief of the Microbiology Department of H. Son Dureta, for continuous support to this project, and C. Vidal and C. Santos for inestimable collaboration in the sequencing experiments.
###end p 81
###begin title 82
References
###end title 82
###begin article-title 83
Resistance to beta-lactam antibiotics.
###end article-title 83
###begin article-title 84
Penicillin-binding proteins and beta-lactam resistance.
###end article-title 84
###begin article-title 85
beta-lactamases in laboratory and clinical resistance.
###end article-title 85
###begin article-title 86
Nosocomial infections in adult intensive-care units.
###end article-title 86
###begin article-title 87
Clinical significance of beta-lactamase induction and stable derepression in gram-negative rods.
###end article-title 87
###begin article-title 88
###xml 83 105 80 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas aeruginosa</italic>
###xml 83 105 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Molecular mechanisms of beta-lactam resistance mediated by AmpC hyperproduction in Pseudomonas aeruginosa clinical strains.
###end article-title 88
###begin article-title 89
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 44 64 44 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Citrobacter freundii</italic>
###xml 44 64 <span type="species:ncbi:546">Citrobacter freundii</span>
DNA sequence differences of ampD mutants of Citrobacter freundii.
###end article-title 89
###begin article-title 90
###xml 62 84 59 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas aeruginosa</italic>
###xml 123 127 120 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1669</italic>
###xml 140 144 137 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 62 84 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Constitutive high expression of chromosomal beta-lactamase in Pseudomonas aeruginosa caused by a new insertion sequence (IS1669) located in ampD.
###end article-title 90
###begin article-title 91
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 33 55 33 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas aeruginosa</italic>
###xml 33 55 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Inactivation of the ampD gene in Pseudomonas aeruginosa leads to moderate-basal-level and hyperinducible AmpC beta-lactamase expression.
###end article-title 91
###begin article-title 92
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 86 106 86 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Citrobacter freundii</italic>
###xml 86 106 <span type="species:ncbi:546">Citrobacter freundii</span>
Inactivation of the ampD gene causes semiconstitutive overproduction of the inducible Citrobacter freundii beta-lactamase.
###end article-title 92
###begin article-title 93
The negative regulator of beta-lactamase induction AmpD is a N-acetyl-anhydromuramyl-L-alanine amidase.
###end article-title 93
###begin article-title 94
beta-lactamase induction in Gram-negative bacteria is intimately linked to peptidoglycan recicling.
###end article-title 94
###begin article-title 95
###xml 25 50 25 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Citrobacter freundii ampC</italic>
###xml 25 45 <span type="species:ncbi:546">Citrobacter freundii</span>
Regulatory components in Citrobacter freundii ampC beta-lactamase induction.
###end article-title 95
###begin article-title 96
###xml 62 82 62 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Enterobacter cloacae</italic>
###xml 145 161 145 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 62 82 <span type="species:ncbi:550">Enterobacter cloacae</span>
###xml 145 161 <span type="species:ncbi:562">Escherichia coli</span>
Inducible cephalosporinase production in clinical isolates of Enterobacter cloacae is controlled by a regulatory gene that has been deleted from Escherichia coli.
###end article-title 96
###begin article-title 97
###xml 0 22 0 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas aeruginosa</italic>
###xml 0 22 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Pseudomonas aeruginosa AmpR is a global transcriptional factor that regulates expression of AmpC and PoxB beta-lactamases, proteases, quorum sensing, and other virulence factors.
###end article-title 97
###begin article-title 98
###xml 62 78 62 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 62 78 <span type="species:ncbi:562">Escherichia coli</span>
Crystal structure of penicillin binding protein 4 (dacB) from Escherichia coli, both in the native form and covalently linked to various antibiotics.
###end article-title 98
###begin article-title 99
###xml 58 74 58 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 58 74 <span type="species:ncbi:562">Escherichia coli</span>
Physiological functions of D-alanine carboxipeptidases in Escherichia coli.
###end article-title 99
###begin article-title 100
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 0 16 <span type="species:ncbi:562">Escherichia coli</span>
Escherichia coli CreBC is a global regulator of gene expression that responds to growth in minimal media.
###end article-title 100
###begin article-title 101
Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents.
###end article-title 101
###begin article-title 102
###xml 128 150 128 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas aeruginosa</italic>
###xml 128 150 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Evaluation of a microarray-hybridyzation based method applicable for discovery of single nucleotide polymorphisms (SNPs) in the Pseudomonas aeruginosa genome.
###end article-title 102
###begin article-title 103
###xml 32 48 32 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 75 79 75 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dacB</italic>
###xml 32 48 <span type="species:ncbi:562">Escherichia coli</span>
Penicillin-binding protein 4 of Escherichia coli: molecular cloning of the dacB gene, controlled overexpression, and alterations in murein composition.
###end article-title 103
###begin article-title 104
###xml 108 124 108 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 108 124 <span type="species:ncbi:562">Escherichia coli</span>
Endopeptidase penicillin-binding proteins 4 and 7 play auxiliary roles in determining uniform morphology of Escherichia coli.
###end article-title 104
###begin article-title 105
Regulation of enterobacterial cephalosporinase production: the role of a membrane-bound sensory transducer.
###end article-title 105
###begin article-title 106
Bacterial cell wall recycling provides cytosolic muropeptides as effectors for beta-lactamase induction.
###end article-title 106
###begin article-title 107
Penicillin-binding proteins and induction of AmpC beta-lactamase.
###end article-title 107
###begin article-title 108
###xml 29 51 29 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas aeruginosa</italic>
###xml 29 51 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Stepwise upregulation of the Pseudomonas aeruginosa chromosomal cephalosporinase conferring high level beta-lactam resistance involves three AmpD homologues.
###end article-title 108
###begin article-title 109
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampD</italic>
###xml 115 137 112 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas aeruginosa</italic>
###xml 115 137 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Benefit of having multiple ampD genes for acquiring beta-lactam resistance without losing fitness and virulence in Pseudomonas aeruginosa.
###end article-title 109
###begin article-title 110
###xml 72 94 72 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas aeruginosa</italic>
###xml 72 94 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Role of ampD homologs in overproduction of AmpC in clinical isolates of Pseudomonas aeruginosa.
###end article-title 110
###begin article-title 111
###xml 43 46 43 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">amp</italic>
###xml 52 57 52 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">blrAB</italic>
###xml 114 123 111 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aeromonas</italic>
Genetic linkage of the penicillinase gene, amp, and blrAB, encoding the regulador of beta-lactamase expression in Aeromonas Spp.
###end article-title 111
###begin article-title 112
###xml 79 99 79 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aeromonas hydrophila</italic>
###xml 79 99 <span type="species:ncbi:644">Aeromonas hydrophila</span>
Role of the 'cre/blr-tag' DNA sequence in regulation of gene expression by the Aeromonas hydrophila beta-lactamase regulator, BlrA.
###end article-title 112
###begin article-title 113
###xml 62 79 62 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aeromonas jandaei</italic>
###xml 62 79 <span type="species:ncbi:650">Aeromonas jandaei</span>
Expression of the AsbA1, OXA-12, and AsbM1 beta-lactamases in Aeromonas jandaei AER 14 is coordinated by a two-component regulon.
###end article-title 113
###begin article-title 114
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sacB</italic>
###xml 110 132 110 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas aeruginosa</italic>
###xml 110 132 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Combined sacB-based negative selection and cre-lox antibiotic marker recycling for efficient gene deletion in Pseudomonas aeruginosa.
###end article-title 114
###begin article-title 115
###xml 28 50 28 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas aeruginosa</italic>
###xml 28 55 <span type="species:ncbi:208964">Pseudomonas aeruginosa PAO1</span>
Complete genome sequence of Pseudomonas aeruginosa PAO1: an opportunistic pathogen.
###end article-title 115
###begin article-title 116
###xml 0 22 0 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas aeruginosa</italic>
###xml 0 22 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Pseudomonas aeruginosa genome database and PseudoCAP: facilitating community-based, continually updated, genome annotation.
###end article-title 116
###begin article-title 117
###xml 46 68 46 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas aeruginosa</italic>
###xml 46 68 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
PBP3 inhibition elicits adaptive responses in Pseudomonas aeruginosa.
###end article-title 117
###begin p 118
The authors have declared that no competing interests exist.
###end p 118
###begin p 119
This work was supported by the Ministerio de Educacion y Ciencia of Spain (SAF2006-08154), the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III through the Spanish Network for the Research in Infectious Diseases (REIPI C03/14 and RD06/0008), and the Govern de les Illes Balears (PROGECIB-9A). AD is a recipient of a predoctoral stipend provided by the DFG-sponsored European Graduate School program "Pseudomonas: Pathogenicity and Biotechnology". Financial support from the Helmholtz Gemeinschaft is also gratefully acknowledged. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.
###end p 119

